all strengths of Digitek (digoxin tablets) are being recalled
May 2008
On April 28, 2008 the FDA notified healthcare professionals that all strengths of Digitek (digoxin tablets) are being recalled due to the possibility that the tablets may contain twice the approved level of active ingredient....
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote